HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment
admin@pathologynews.com2023-07-18T11:26:28+00:00HNL Lab Medicine, a leading clinical diagnostics laboratory, is pleased to announce an investment in a new digital pathology initiative. HNL Lab Medicine has selected solutions from Proscia, a digital pathology software company, and Leica Biosystems, a manufacturer of high-quality imaging hardware, to establish an advanced digital pathology practice. This investment will enhance the lab’s diagnostic capabilities, improve efficiency, and ultimately provide better patient care.










